18
H index
27
i10 index
1280
Citations
Patricia M. Danzon : Citation Profile
University of Pennsylvania | RESEARCH PRODUCTION: 43 Articles 17 Papers 3 Books 6 Chapters EDITOR: Books edited RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
36 years (1982 - 2018). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Patricia M. Danzon. | Is cited by:
| Cites to:
|
Main data
Where Patricia M. Danzon has published?
| Working Papers Series with more than one paper published | # docs |
|---|---|
| NBER Working Papers / National Bureau of Economic Research, Inc | 10 |
| Monograph / Office of Health Economics | 3 |
| Working Papers / The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State | 2 |
Recent works citing Patricia M. Danzon (2025 and 2024)
Year  | Title of citing document |
|---|---|
| 2024 | . Full description at Econpapers || Download paper |
| 2024 | The Impact of Acquisitions on Inventors Turnover in the Biotechnology Industry. (2022). Riccaboni, Massimo ; van Lidth, Jeroen ; Parisi, Federica ; Verginer, Luca. In: Papers. RePEc:arx:papers:2203.12968. Full description at Econpapers || Download paper |
| 2024 | How does medical insurance contribution affect corporate value? Evidence from China. (2024). Wang, Jian ; Lu, Jiankun ; Li, Xuchao. In: Journal of Risk & Insurance. RePEc:bla:jrinsu:v:91:y:2024:i:1:p:57-92. Full description at Econpapers || Download paper |
| 2025 | Legislation, Regulation and Litigation: Demand for U.S. Legal Services in Historical Perspective. (2025). Slattery, Cailin ; Reshef, Ariell. In: CESifo Working Paper Series. RePEc:ces:ceswps:_11661. Full description at Econpapers || Download paper |
| 2024 | Seeking efficiency or price gouging? Evidence from pharmaceutical mergers. (2024). Hammoudeh, Mosab ; Nain, Amrita. In: Journal of Corporate Finance. RePEc:eee:corfin:v:87:y:2024:i:c:s0929119924000853. Full description at Econpapers || Download paper |
| 2024 | Health policy, price regulation, and innovation: Evidence from China’s vaccine industry. (2024). Shi, Ce Matthew ; Geng, Hao. In: Journal of Development Economics. RePEc:eee:deveco:v:167:y:2024:i:c:s0304387823001852. Full description at Econpapers || Download paper |
| 2024 | The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis. (2024). Hollis, Aidan ; Grootendorst, Paul ; Guh, Daphne P ; Zhang, Wei ; Anis, Aslam H. In: Health Policy. RePEc:eee:hepoli:v:144:y:2024:i:c:s0168851024000745. Full description at Econpapers || Download paper |
| 2024 | Market discipline and policy loans. (2024). Niehaus, Greg ; Chiang, Chia-Chun. In: Journal of Banking & Finance. RePEc:eee:jbfina:v:159:y:2024:i:c:s0378426623002716. Full description at Econpapers || Download paper |
| 2024 | The interplay between product development failures and alliance portfolio properties in the formation of exploration versus exploitation alliances. (2024). Ozmel, Umit ; Bae, Joonhyung. In: Journal of Business Research. RePEc:eee:jbrese:v:177:y:2024:i:c:s0148296324001267. Full description at Econpapers || Download paper |
| 2024 | Internal versus external capital markets and risk-taking. (2024). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: International Review of Economics & Finance. RePEc:eee:reveco:v:92:y:2024:i:c:p:503-519. Full description at Econpapers || Download paper |
| 2024 | How does market competition affect enterprise cooperative innovation? The moderating role of intellectual property protection and government subsidies. (2024). Zhang, Danni ; Cheng, LI ; Yu, Yiyong. In: Technovation. RePEc:eee:techno:v:137:y:2024:i:c:s0166497224001524. Full description at Econpapers || Download paper |
| 2024 | Individuals social concern, externalities and voluntary vaccination: Monopoly and first-best public policy. (2024). Kundu, Sumana ; Pal, Rupayan. In: Indira Gandhi Institute of Development Research, Mumbai Working Papers. RePEc:ind:igiwpp:2024-023. Full description at Econpapers || Download paper |
| 2025 | How do underwriting and investment activities affect P&C insurers’ capital adjustments? Evidence from Canada. (2025). Lai, Van Son ; Guidara, Alaa ; Zhao, Yang ; Yu, Min-Teh. In: Review of Quantitative Finance and Accounting. RePEc:kap:rqfnac:v:64:y:2025:i:2:d:10.1007_s11156-024-01314-z. Full description at Econpapers || Download paper |
| 2024 | Passthrough of Retail Price Regulation in the Market for Pharmaceuticals. (2024). Markkanen, Jaakko. In: ETLA Working Papers. RePEc:rif:wpaper:123. Full description at Econpapers || Download paper |
| 2024 | The Effect of Branch Office Locations on Technical Efficiency: Evidence from the Indian Life Insurance Industry. (2024). Siddiqui, Shoaib Alam. In: Global Business Review. RePEc:sae:globus:v:25:y:2024:i:6:p:1559-1575. Full description at Econpapers || Download paper |
| 2024 | Insurance Development, Global Economic Policy Uncertainty and Geopolitical Risk: The Asymmetric Relationship Evidence from ASEAN-5. (2024). Soukchalern, Phongsili ; Kyophilavong, Phouphet ; Lim, Soyoung. In: Journal of Asian Economic Integration. RePEc:sae:jfasei:v:6:y:2024:i:2:p:154-168. Full description at Econpapers || Download paper |
Patricia M. Danzon has edited the books:
| Year | Title | Type | Cited |
|---|
Works by Patricia M. Danzon:
| Year | Title | Type | Cited |
|---|---|---|---|
| 1988 | The Political Economy of Workers Compensation: Lessons for Product Liability. In: American Economic Review. [Full Text][Citation analysis] | article | 2 |
| 1990 | The Effects of Malpractice Litigation on Physicians Fees and Incomes. In: American Economic Review. [Full Text][Citation analysis] | article | 7 |
| .() In: . [Full Text][Citation analysis] This paper has nother version. Agregated cites: 7 | paper | ||
| 1991 | Liability for Medical Malpractice In: Journal of Economic Perspectives. [Full Text][Citation analysis] | article | 82 |
| 2000 | Liability for medical malpractice.(2000) In: Handbook of Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 82 | chapter | |
| 1994 | Health Care Reform In: Australian Economic Review. [Full Text][Citation analysis] | article | 8 |
| 2004 | Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 62 |
| 2004 | Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand.(2004) In: NBER Chapters. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 62 | chapter | |
| 2003 | Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand.(2003) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 62 | paper | |
| 1994 | The Swedish patient compensation system: Myths and realities In: International Review of Law and Economics. [Full Text][Citation analysis] | article | 3 |
| 2008 | Crises in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market In: Journal of Banking & Finance. [Full Text][Citation analysis] | article | 10 |
| 1997 | Price, Financial Quality, and Capital Flows in Insurance Markets In: Journal of Financial Intermediation. [Full Text][Citation analysis] | article | 107 |
| 2000 | Cross-national price differences for pharmaceuticals: how large, and why? In: Journal of Health Economics. [Full Text][Citation analysis] | article | 94 |
| 1982 | Hospital `profits : The effects of reimbursement policies In: Journal of Health Economics. [Full Text][Citation analysis] | article | 16 |
| 2002 | Welfare effects of supplementary insurance: a comment In: Journal of Health Economics. [Full Text][Citation analysis] | article | 10 |
| 2005 | Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances In: Journal of Health Economics. [Full Text][Citation analysis] | article | 84 |
| 2003 | Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances.(2003) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 84 | paper | |
| 1985 | Liability and liability insurance for medical malpractice In: Journal of Health Economics. [Full Text][Citation analysis] | article | 21 |
| 1984 | Separation of the redistributive and allocative functions of government : A public choice perspective In: Journal of Public Economics. [Full Text][Citation analysis] | article | 5 |
| 2012 | Regulation of the Biopharmaceutical Industry In: Chapters. [Full Text][Citation analysis] | chapter | 0 |
| 2012 | Effects of Regulation on Drug Launch and Pricing in Interdependent Markets In: Advances in Health Economics and Health Services Research. [Full Text][Citation analysis] | chapter | 28 |
| 2008 | Effects of Regulation on Drug Launch and Pricing in Interdependent Markets.(2008) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 28 | paper | |
| 1990 | THE EFFECTS OF MALPRACTICE LITIGATION ON PHYSICIANS FEES AND INCOME. In: University of Chicago - George G. Stigler Center for Study of Economy and State. [Citation analysis] | paper | 4 |
| 1990 | Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects In: University of Chicago - George G. Stigler Center for Study of Economy and State. [Citation analysis] | paper | 2 |
| 2002 | Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy In: Center for Policy Research Policy Briefs. [Full Text][Citation analysis] | paper | 0 |
| In: . [Full Text][Citation analysis] | paper | 0 | |
| 2007 | At what price? In: Nature. [Full Text][Citation analysis] | article | 3 |
| 2014 | Regulation of the Pharmaceutical-Biotechnology Industry In: NBER Chapters. [Full Text][Citation analysis] | chapter | 4 |
| 1999 | The Effects of Price Regulation on Productivity in Pharmaceuticals In: NBER Chapters. [Full Text][Citation analysis] | chapter | 2 |
| 2004 | Mergers and Acquisitions in the Pharmaceutical and Biotech Industries In: NBER Working Papers. [Full Text][Citation analysis] | paper | 79 |
| 2007 | Mergers and acquisitions in the pharmaceutical and biotech industries.(2007) In: Managerial and Decision Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 79 | article | |
| 2011 | Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement In: NBER Working Papers. [Full Text][Citation analysis] | paper | 15 |
| 2015 | Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement.(2015) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 15 | article | |
| 2011 | Vaccine Supply: Effects Of Regulation And Competition In: NBER Working Papers. [Full Text][Citation analysis] | paper | 9 |
| 2011 | Vaccine Supply: Effects of Regulation and Competition.(2011) In: International Journal of the Economics of Business. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 9 | article | |
| 2011 | Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets In: NBER Working Papers. [Full Text][Citation analysis] | paper | 20 |
| 2012 | Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context In: NBER Working Papers. [Full Text][Citation analysis] | paper | 17 |
| 2015 | Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context.(2015) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 17 | article | |
| 2002 | Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality In: NBER Working Papers. [Full Text][Citation analysis] | paper | 70 |
| 2003 | The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s In: NBER Working Papers. [Full Text][Citation analysis] | paper | 78 |
| 2005 | The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s.(2005) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 78 | article | |
| 1997 | Trade and Price Differentials for Pharmaceuticals: Policy Options In: Monograph. [Full Text][Citation analysis] | book | 5 |
| 2000 | Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison In: Monograph. [Full Text][Citation analysis] | book | 4 |
| 2002 | The Life Cycle of Pharmaceuticals: A Cross-National Perspective In: Monograph. [Full Text][Citation analysis] | book | 6 |
| 2011 | Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? In: Occasional Paper. [Full Text][Citation analysis] | paper | 2 |
| 1994 | Tort Reform: The Case of Medical Malpractice. In: Oxford Review of Economic Policy. [Citation analysis] | article | 1 |
| 1990 | Alternative Liability Regimes for Medical Injuries In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 4 |
| 1983 | Contingent Fees for Personal Injury Litigation In: Bell Journal of Economics. [Full Text][Citation analysis] | article | 54 |
| 2018 | Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues In: PharmacoEconomics. [Full Text][Citation analysis] | article | 13 |
| 2015 | Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? In: International Journal of the Economics of Business. [Full Text][Citation analysis] | article | 0 |
| 1997 | Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU In: International Journal of the Economics of Business. [Full Text][Citation analysis] | article | 34 |
| 1993 | The Economic Implications of Public Disability Insurance in the United States. In: Journal of Labor Economics. [Full Text][Citation analysis] | article | 13 |
| 2002 | Health Insurance and the Growth in Pharmaceutical Expenditures In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 19 |
| 1984 | The Frequency and Severity of Medical Malpractice Claims. In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 36 |
| 1993 | Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment. In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 0 |
| 2000 | Does Regulation Drive out Competition in Pharmaceutical Markets? In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 107 |
| 2001 | Workers Compensation Rate Regulation: How Price Controls Increase Costs. In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 11 |
| 1997 | Tort Liability: A Minefield for Managed Care? In: The Journal of Legal Studies. [Full Text][Citation analysis] | article | 17 |
| 2001 | Comments on The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions. In: The Journal of Legal Studies. [Full Text][Citation analysis] | article | 0 |
| 1994 | Price Cutting in Liability Insurance Markets. In: The Journal of Business. [Full Text][Citation analysis] | article | 30 |
| 2000 | Rate Regulation, Safety Incentives, and Loss Growth in Workers Compensation Insurance. In: The Journal of Business. [Full Text][Citation analysis] | article | 6 |
| 2002 | A general model of the impact of absenteeism on employers and employees In: Health Economics. [Full Text][Citation analysis] | article | 44 |
| 1999 | Medical negligence and the NHS: an economic analysis In: Health Economics. [Full Text][Citation analysis] | article | 8 |
| 1995 | A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
| 1982 | Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
| 1983 | Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
| 1983 | Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 1 |
| 2007 | Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion In: Managerial and Decision Economics. [Full Text][Citation analysis] | article | 6 |
| In: . [Full Text][Citation analysis] | paper | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team